RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a leader in developing treatments for seizure disorders, will unveil its first-quarter financials for 2024 on May 8, prior to market opening.
Investors can access the details on the company’s investor relations webpage. This announcement comes as Marinus continues to make strides in the pharmaceutical industry with its focus on innovative therapeutics.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.